B
Bullisch
Bullisch · 25%WBA
$10.84
Szenariopreis
$11.980
+0.060 (+0.50%)Zum Schluss
Loading chart…
- Hoch
- 12.110
- Eröffnung
- 11.915
- Volumengewichteter Durchschnittskurs
- 12.00
- Volumen
- 452.08M
- Marktkap.
- 10.52B
- Tief
- 11.900
- Umsatz
- 5.42B
- EV/EBITDA, TTM
- 11.73
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Analystenbewertungen (24)
-4.42% Abwärtspotenzial
Kaufen
15 Kaufen
9 Halten
0 Verkaufen
Aktuell: 11.98
Tief
11.45
Durchschnitt
11.45
Hoch
11.45
Deutsche Bank
Starker Verkauf
$9
2025-02-28
Deutsche Bank
2025-02-28
Kursziel
$9
Starker Verkauf
Truist Securities
Halten
$12
2025-01-31
Truist Securities
2025-01-31
Kursziel
$12
Halten
Truist Securities
Halten
$13
2025-01-16
Truist Securities
2025-01-16
Kursziel
$13
Halten
RBC Capital
Halten
$12
2025-01-15
RBC Capital
2025-01-15
Kursziel
$12
Halten
B of A Securities
Verkaufen
$8.5
2025-01-13
B of A Securities
2025-01-13
Kursziel
$8.5
Verkaufen
Bewertungskennzahlen
Das aktuelle erwartete KGV von Walgreens Boots Alliance Inc (WBA) beträgt 7.78, verglichen mit dem 5-Jahres-Durchschnitt von 7.94.
Alphio-AI-Kursszenarien für WBA
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.
Event-Zeitleiste
News
2.003-22CNBCRising Menstrual Product Prices Squeeze Consumers
4.503-17CNBCOil Prices Rise, Boosting Stock Market Performance
8.002-20Yahoo FinanceWalgreens Lays Off 469 Employees Amid Business Reorganization
4.502-06CNBCDow Jones Index Surpasses 50,000 for the First Time
8.502-02CNBCAnalysis of Store Openings and Closures in U.S. Retail Sector
WBA FAQ – beantwortet von Alphio AI
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey. It operates in the Consumer Non-Cyclicals sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).
24 analysts cover WBA: 15 rate it Buy, 9 Hold and 0 Sell. The average price target is 11.45.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.